Takeda’s Dengue Vaccine Met Phase 3 Goals - PrecisionVaccinations

Takeda’s Dengue Vaccine Met Phase 3 Goals  PrecisionVaccinations

The pivotal Phase 3 clinical trial of dengue vaccine candidate TAK-003 was reported to have met the primary efficacy endpoint. This is important news since ...



Comments

Popular posts from this blog